Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2024

Apr 10, 2024

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Announcement Type

New announcement

Date of this announcement

Thursday April 11, 2024

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
TLX	ORDINARY FULLY PAID	5,674,635	11/04/2024

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 6

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

Registration number

ACN 616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

New announcement

1.5 Date of this announcement

11/4/2024

Appendix 2A - Application for quotation of securities

2 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details: Announcement Date and Announcement Title Selected Appendix 3B to submit quotation Time request 05-Mar-2024 09:17 New - Proposed issue of securities - A placement or other type of issue TLX

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? No

Appendix 2A - Application for quotation of securities

3 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Placement Details

ASX +security code and description TLX : ORDINARY FULLY PAID

Issue date

11/4/2024

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

category.
		Total percentage of +securities held
Number of +securities held	Number of holders	For example, to enter a value of 50%
		please input as 50.00
1 - 1,000		%
1,001 - 5,000		%
5,001 - 10,000		%
10,001 - 100,000		%
100,001 and over		%

Appendix 2A - Application for quotation of securities

4 / 6

Appendix 2A - Application for quotation of securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities to be quoted

5,674,635

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Telix has issued 5,674,635 fully paid ordinary shares (Consideration Shares) equivalent to US$42.5 million (according to the 5 March 2024 App 3B formula). Also refer ASX announcement 11 April 2024.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

11.500000

Any other information the entity wishes to provide about the +securities to be quoted

The Consideration Shares to be issued to management, employees or key consultants of ARTMS will be subject to voluntary escrow and will not be able to be traded for a period of 12 months from the date of issue of the Consideration Shares. The balance of the Consideration Shares will also be subject to voluntary escrow restrictions for a period of 3 months from the date of issue of the Consideration Shares.

Appendix 2A - Application for quotation of securities

5 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	330,450,431
4.2 Unquoted +securities (total number of each +class of +securities issued	but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAR : PERFORMANCE RIGHTS	2,523,720
TLXAP : SHARE RIGHTS	1,195,000
TLXAO : SHARE APPRECIATION RIGHTS	8,117,254
TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37	584,992
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38	690,357
TLXAS : PERFORMANCE SHARE INCENTIVE RIGHTS	440,000

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Appendix 2A - Application for quotation of securities

6 / 6